Primary Tumor Resection for Metastatic Colorectal, Gastric and Pancreatic Cancer Patients: In Search of Scientific Evidence to Inform Clinical Practice

Scartozzi, Mario;
2023-01-01

Abstract

The management of the primary tumor in metastatic colorectal, gastric and pancreatic cancer patients may be challenging. Indeed, primary tumor progression could be associated with severe symptoms, compromising the quality of life and the feasibility of effective systemic therapy, and might result in life-threatening complications. While retrospective series have suggested that surgery on the primary tumor may confer a survival advantage even in asymptomatic patients, randomized trials seem not to definitively support this hypothesis. We discuss the evidence for and against primary tumor resection for patients with metastatic gastrointestinal (colorectal, gastric and pancreatic) cancers treated with systemic therapies and put in context the pros and cons of the onco-surgical approach in the time of precision oncology. We also evaluate current ongoing trials on this topic, anticipating how these will influence both research and everyday practice.
2023
Inglese
15
3
900
25
Esperti anonimi
scientifica
Colorectal cancer; Gastric adenocarcinoma; Pancreatic adenocarcinoma; Primary tumor resection; Stage IV; Surgery
Goal 3: Good health and well-being
no
Fanotto, Valentina; Salani, Francesca; Vivaldi, Caterina; Scartozzi, Mario; Ribero, Dario; Puzzoni, Marco; Montagnani, Francesco; Leone, Francesco; Va ...espandi
1.1 Articolo in rivista
info:eu-repo/semantics/article
1 Contributo su Rivista::1.1 Articolo in rivista
262
15
open
Files in This Item:
File Size Format  
primarytumourresectionCancers2023.pdf

open access

Type: versione editoriale
Size 392.85 kB
Format Adobe PDF
392.85 kB Adobe PDF View/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Questionnaire and social

Share on:
Impostazioni cookie